Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 6 Colorectal Neoplasms 4 Brain Neoplasms 3 Radiodermatitis 2 Pancreatic Neoplasms 2 Pain, Postoperative 2 Lung Neoplasms 2 Leiomyoma 2 Head and Neck Neoplasms 2 Warts 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Skin Diseases 1 Sigmoid Neoplasms 1 Severe Acute Respiratory Syndrome 1 Sarcoma 1 Rectal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Neuroinflammatory Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Mastocytosis 1 Lymphoma, Non-Hodgkin 1 Lymphoma 1 Lung Injury 1 Locally Advanced Cervical Cancer 1 Limited Stage Small Cell Lung Cancer 1 Leukemia, Myeloid, Acute 1

Interventions

Capecitabine 41 Oxaliplatin 39 Fluorouracil 29 Leucovorin 23 Radiotherapy 21 Cetuximab 14 Bevacizumab 14 Irinotecan 13 Nivolumab 12 Magnetic Resonance Spectroscopy 11 Specimen Handling 9 Surgical Procedures, Operative 8 Folfox protocol 8 Drug Therapy 8 pembrolizumab 7 Radiotherapy, Intensity-Modulated 7 Chemoradiotherapy 7 Biopsy 7 trifluridine tipiracil drug combination 6 Radiation 6 tislelizumab 5 sintilimab 5 regorafenib 5 dehydroftorafur 5 X-Rays 5 Surveys and Questionnaires 5 Sigmoidoscopy 5 Endoscopy 5 Consolidation Chemotherapy 5 spartalizumab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Rectal Neoplasms × Sodium Chloride × 1 year × Clear all

NCT07385898 2026-02-04

Dex

The Second Affiliated Hospital of Chongqing Medical University

Phase NA Completed

Gastrointestinal

Rectal Neoplasms, Sigmoid Neoplasms, Lung Injury

Data powered by HemOnc (CC BY 4.0) Colophon ⚡